Leptin: A novel target for reducing the risk of heart disease in obesity

Sherma Zibadi, Ronald Ross Watson

Research output: Contribution to specialist publicationArticle


These studies lead us to the conclusion that leptin initiates or attenuates the adverse heart remodeling associated with obesity and other hyperleptinemic conditions, which may in turn contribute to the clinical syndrome of heart failure. This will likely provide the basis for future development of leptin-moduiator therapeutics to prevent or lessen adverse cardiac remodeling and dysfunction in obese populations.

Original languageEnglish (US)
Number of pages2
Specialist publicationINFORM - International News on Fats, Oils and Related Materials
StatePublished - Nov 1 2009


ASJC Scopus subject areas

  • Biotechnology
  • Food Science
  • Chemistry(all)

Cite this